Perfil de seguridad BPC-157 presenta uno de los perfiles de seguridad preclnica ms favorables documentados para un pptido de investigacin, aunque la evidencia humana sistemtica es escasa
doi: 10.3389/fnut.2026.1778473 Received 31 December 2025 Revised 09 March 2026 Accepted 26 March 2026 Published 28 April 2026 Volume 13 - 2026 Edited by Huanling Lai, Guangzhou National Laboratory, China Reviewed by Jiayi Zhou, University of North Carolina at Chapel Hill, United States Mairepaiti Halimulati, The University of Texas at Austin, United States Updates Copyright 2026 Sun, Sun, Nan, Wang, Sun, Shi, Yang and Wang
Gellerich FN, Gizatullina Z, Trumbeckaite S, Nguyen HP, Pallas T, Arandarcikaite O, et al
10.1021/acs.jafc.1c03420 112 ZhuL.YeC.HuB.XiaH.BianQ.LiuY.et al (2022)
Buzio, L
Sermorelin BPC-157 and Sermorelin are both peptides often discussed in recovery, performance, and longevity contexts, but they differ significantly in mechanism, purpose, and evidence base